Persistent changes in corticotropin-releasing factor systems due to early life stress: Relationship to the pathophysiology of major depression and post-traumatic stress disorder

Psychopharmacology Bulletin

Volumn 33, Issue 2, 1997, Pages 185-192

  Heim, Christine ^a   Owens, Michael J ^b   Plotsky, Paul M ^b   Nemeroff, Charles B ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b School of Medicine ^*

Author keywords

Corticotropin releasing factor; Early life stress; Hypothalamic pituitary adrenal axis; Major depressive disorder; Post traumatic stress disorder

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; IDAZOXAN; IMIPRAMINE; PHENELZINE; TRICYCLIC ANTIDEPRESSANT AGENT;

DEPRESSION; HORMONAL REGULATION; HORMONE RELEASE; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MENTAL DISEASE; PATHOPHYSIOLOGY; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; STRESS;

ADULT; ANIMALS; CHILD; CORTICOTROPIN-RELEASING HORMONE; DEPRESSIVE DISORDER; FEMALE; HUMANS; LIFE CHANGE EVENTS; MACACA RADIATA; MALE; RATS; STRESS; STRESS DISORDERS, POST-TRAUMATIC;

EID: 0030739453     PISSN: 00485764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Arato, M; Banki, CM; Bisette, G; and Nemeroff, CB. Elevated CSF CRF in suicide victims. Biol. Psychiatry 25:355-359, 1989.
2. Banki, CM; Karmaksi, L; Bissette, G; and Nemeroff, CB. Cerebrospinal fluid neuropeptides in mood disorder and dementia. J. Affect. Disord. 25:39-46, 1992.
3. Brady, LS; Whitfield, HJ; Fox, RJ; Gold, PW; and Herkenham, M. Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineral corticoid receptor gene expression in rat brain. J. Clin. invest. 87:831-837, 1991.
4. Brady, LS; Gold, P; Herkenham, M; Lynn, A; and Whitfield, HJ. The antidepressants fluoxetine, idazoxan, and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: Therapeutic implications. Brain Res. 572:117-125, 1992.
5. Bremner, JD; Southwick, SM; Johnson, DR; Yehuda, R; and Charney, DS. Childhood physical abuse and combat-related posttraumatic stress disorder in Vietnam veterans. Am. J. Psychiatry 150:235-239, 1993.
6. Bremner, JD; Licino, J; Darnell, A; Krystal, JH; Owens, MJ; Southwick, SM; Nemeroff, CB; and Charney, DS. Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder. Am. J. Psychiatry, in press.
7. Browne, A, and Finkelhor, D. Impact of childhood sexual abuse. Psychol. Bull. 99:66-77, 1986.
8. Butler, PD; Weiss, JM; Stout, JC; and Nemeroff, CB. Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus. J. Neurosci. 10:176-183, 1990.
9. Coplan, JD; Andrews, MW; Rosenblum, LA; Owens, MJ; Friedman, S; Gorman, JM; and Nemeroff, CB. Persistent elevations of cerebrospinal fluid concentrations of corticotropin-releasing factor in adult nonhuman primates exposed to early-life stressors: Implications for the pathophysiology of mood and anxiety disorders. Proc. Natl. Acad. Sci. USA 93:1619-1623, 1996.
10. DeBellis, MD; Chrousos, GP; Dorn, LD; Burke, L; Helmers, K; Kling, MA; Trickett, PK; and Putnam, FW. Hypothalamic pituitary adrenal dysregulation in sexually abused girls. J. Clin. Endocrinol. Metab. 78:249-255, 1994.
11. DeBellis, MD; Gold, P; Geracioti, TD; Listwak, SJ; and Kling, MA. Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopression in patients with major depression. Am. J. Psychiatry 150:656-657, 1993.
12. Denenberg, VH. Critical periods, stimulus input, and emotional reactivity: A theory of infantile stimulation. Psychol. Rev. 71:335-351, 1964.
13. Dunn, AJ, and Berridge, CW. Physiological and behavioral responses to corticotropin-releasing factor administration: Is CRF a mediator of anxiety or stress responses? Brain Res. Rev. 15:71-100, 1990.
14. Feldman, TB. Alprazolam in the treatment of posttraumatic stress disorder. J. Clin. Psychiatry 48:216-217, 1987.
15. Freud, S. The Standard Edition of the Complete Psychological Works of Sigmund Freud. Vol.1. London: Hogarth, 1966.
16. Friedman, MJ, and Southwick, SC. Toward pharmacotherapy for post-traumatic stress disorder. In: Friedman, MJ; Charney, DS; and Deutch, AY, eds. Neurobiological and Clinical Consequences of Stress. Philadelphia: Lippincott-Raven, 1995.
17. Gold, PW; Chrousos, G; Kellner, C; Post, R; Roy, A; Augerinos, P; Schulte, H; Oldfield, E; and Loriaux, D. Psychiatric implications of basic and clinical studies with corticotropin-releasing factor. Am. J. Psychiatry 141:619-627, 1984.
18. Grigoriadis, DE; Pearsall, D; and DeSouza, E. Effects of chronic antidepressant and benzodiazepine treatment on corticotropin releasing factor receptors in rat brain and pituitary. Neuropsychopharmacology 2:53-60, 1989.
19. Heim, C; Ehlert, U; Hanker, JP; and Hellhammer, DH. "Abuse-Related Post-Traumatic Stress Disorder and Alterations of the Hypothalamic-Pituitary-Adrenal Axis in Women With Chronic Pelvic Pain." In Press.
20. Hitchcock, J, and Davis, M. Lesions of the amygdala, but not of the cerebellum, block conditioned fear measured with the potentiated startle paradigm. Behav. Neurosci. 100:11-22, 1986.
21. Holsboer, F; Gerken, A; Stalla, GK; and Mueller, OA. ACTH, cortisol and corticosterone output after ovine corticotropin-releasing factor challenge during depression and after recovery. Biol. Psychiatry 20:276-286, 1985.
22. Kendler, KS; Kessler, RC; Neale, MC; Heath, AC; and Eaves, LJ. The prediction of major depression in women: Toward an integrated model. Am. J. Psychiatry 150:1139-1148, 1993.
23. Koob, GF; Heinrichs, SC; Menzaghi, F; Pich, EM; and Britton, KT. Corticotropin-releasing factor, stress and behavior. Sem. Neurosci. 6:221-229, 1994.
24. Kosten, TR; Mason, JW; Giller, EL; and Harkness, L. Sustained urinary norepinephrine and epinephrine elevation in posttraumatic stress disorder. Psychoneuroendocrinology 12:13-20, 1987.
25. Ladd, CO; Owens, MJ; and Nemeroff, CB. Persistent changes in corticotropin-releasing factor neuronal systems induced by maternal deprivation. Endocrinology 137:1212-1218, 1996.
26. Levine, S. Infantile experience and resistance to physiological stress. Science 126:405-406, 1957.
27. Liang, KC, and Lee, EHY. Intra-amygdala injections of corticotropin-releasing factor facilitate inhibitory avoidance learning and reduce exploratory behavior in rats. Psychopharmacology 96:232-236, 1988.
28. McCranie, EW; Hyer, LA; Boudewyns, PA; and Woods, MG. Negative parenting behavior, combat exposure and PTSD symptom severity. Test of a person-event interaction model. J. Nerv. Ment. Dis. 180:431-438, 1992.
29. Meaney, MJ; Tannenbaum, P; Francis, D; Bhatnagar, S; Shanks, N; Viau, V; O'Donnell, D; and Plotsky, PM. Early environmental programming of hypothalamic-pituitary-adrenal responses to stress. Sem. Neurosci. 6:247-259, 1994.
30. Melia, KR, and Duman, RS. Involvement of corticotropin-releasing factor in chronic stress regulation of the brain noradrenergic system. Proc. Natl. Acad. Sci. USA 88:8382-8386, 1991.
31. Nemeroff, CB; Widerlov, E; Bisette, G; Walleus, H; Karlsson, L; Eklund, K; Kilts, CD; Loosen, PT; and Vale, W. Elevated concentrations of CSF corticotropin releasing factor like immunoreactivity in depressed patients. Science 226:1342-1344, 1984.
32. Nemeroff, CB; Owens, MJ; Bisette, G; Andorn, AC; and Stanley, M. Reduced corticotropin-releasing factor (CRF) binding sites in the frontal cortex of suicide victims. Arch. Gen. Psychiatry 45:577-579, 1988.
33. Nemeroff, CB; Owens, MJ; Plott, SJ; and Levine, S. Increased density of regional brain CRF binding sites after maternal deprivation. Soc. Neurosci. Abstr. 19:1, 1993.
34. Owens, MJ; Bissette, G; and Nemeroff, CB. Acute effects of alprazolam on the concentrations of corticotropin-releasing factor in the rat brain. Synapse 4:196- 202, 1989.
35. Owens, MJ, and Nemeroff, CB. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol. Rev. 43:425-473, 1991.
36. Owens, MJ; Plotsky, PM; and Nemeroff, CB. Peptides and affective disorders. In: Watson, SJ, ed. Biology of Schizophrenia and Affective Disorders. Washington, DC: American Psychiatric Press, 1996.
37. 2-receptor binding sites in posttraumatic stress disorder. Am. J. Psychiatry 144:1511-1512, 1987.
38. Perry, BD; Southwick, SM; Yehuda, R; and Giller, EL. Adrenergic receptor regulation in posttraumatic stress disorder. In: Giller, EL, ed. Biological Assessment and Treatment of Posttraumatic Stress Disorder. Washington, DC: American Psychiatric Press, 1990.
39. Pihoker, C; Owens, MJ; Kuhn, CM; Schanberg, SM; and Nemeroff, CB. Maternal separation in neonatal rats elicits activation of the hypothalamic-pituitary-adrenal axis: A putative role for corticotropin-releasing factor. Psychoneuroendocrinology 18:485-493, 1993.
40. Plotsky, PM, and Meaney, MJ. Early, postnatal experience alters hypothalamic corticotropin-releasing factor (CRF) mRNA, median eminence CRF content and stress-induced release in adult rats. Mol. Brain Res. 18:195-200, 1993.
41. Raadsheer, FC; Hoogendijk, WJ; Stam, FC; Tilders, FJ; and Swaab, DF. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology 60:436-444, 1994.
42. Raadsheer, FC; van Heerikhuize, JJ; Lucassen, PJ; Tilders, FJ; and Swaab, DF. Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. Am. J. Psychiatry 152:1372-1376, 1995.
43. Risse, SC; Whitters, A; Burke, J; Chen, S; Scurfield, RM; and Raskind, MA. Severe withdrawal symptoms after discontinuation of alprazolam in eight patients with combat-induced posttraumatic stress disorder. J. Clin. Psychiatry 51:206-209, 1990.
44. Rosenbaum, AH; Maruta, T; Schatzberg, AF; Orsulak, PJ; Jiang, NS; Cole, JO; and Schildkraut, JJ. Toward a biochemical classification of depressive disorders. VII: Urinary free cortisol and urinary MHPG in depression. Am. J. Psychiatry 140:314-318, 1983.
45. Rosenblum, SA, and Paully, GS. The effects of varying environmental demands on maternal and infant behavior. Child Dev. 55:305-314, 1984.
46. Rosenblum, LA; Coplan, JD; Friedman, S; Gorman, JM; and Andrews, MW. Adverse early experiences affect noradrenergic and serotonergic functioning in adult primates. Biol. Psychiatry 35:221-227, 1994.
47. Schatzberg, AF, and Nemeroff, CB. The Textbook of Psychopharmacology. Washington, DC: American Psychiatric Press, 1995.
48. Selye, H. A syndrome produced by diverse noxious agents. Nature 138:32-36, 1936.
49. Singewald, N; Zhou, GY; Chen, F; and Philippu, A. Corticotropin-releasing factor modulates basal and stress-induced excitatory amino acid release in the locus coeruleus of conscious rats. Neurosci. Lett. 204:45-48, 1996.
50. Smith, MA; Davidson, MA; Ritchie, JC; Kudler, H; Upper, S; Chappell, P; and Nemeroff, CB. The corticotropin-releasing hormone test in patients with posttraumatic stress disorder. Biol. Psychiatry 26:349-355, 1989.
51. Southwick, SM; Krystal, JH; Johnson, DR; Nagy, LM; Nicolau, A; Heninger, GR; and Charney, DS. Abnormal noradrenergic function in posttraumatic stress disorder. Arch. Gen. Psychiatry 50:266-274, 1993.
52. Stokes, PE; Frazer, A; and Casper, R. Unexpected neuroendocrine transmitter relationships. Psychopharmacol. Bull. 17:72-75, 1981.
53. Valentino, RJ; Foote, SL; and Aston-Jones, G. Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus. Brain Res. 270:363-367, 1983.
54. van der Kolk, BA; Dreyfuss, D; Michaels, M; Shera, D; Berkowitz, R; Fisler, R; and Saxe, G. Fluoxetine in post-traumatic stress disorder. J. Clin. Psychiatry 55:517-522, 1994.
55. Veith, RC; Lewis, N; Langohr, JI; Murburg, MM; Ashleigh, EA; Castillo, S; Peskind, ER; Pascualy, M; Bissette, G; Nemeroff, CB; and Raskind, MA. Effect of desipramine on cerebrospinal fluid concentrations of corticotropin-releasing factor in human subjects. Psychiatry Res. 46:1-8, 1993.
56. von Bardeleben, U; Stalla, GK; Mueller, OA; and Holsboer, F. Blunting of ACTH response to human CRH in depressed patients is avoided by metyrapone pretreatment. Biol. Psychiatry 24:782-786, 1988.
57. Weiss, JM; Stout, JC; Aaron, M; Owens, MJ; and Nemeroff, CB. Experimental studies of anxiety and depression: Locus coeruleus and corticotropin-releasing factor. Brain Res. Bull. 35:561-572, 1994.
58. Yehuda, R; Giller, EL; Southwick, SM; Lowy, MT; and Mason, JW. Hypothalamic-pituitary-adrenal dysfunction in posttraumatic stress disorder. Biol. Psychiatry 30:1031-1048, 1991.
59. Yehuda, R; Giller, EL; Levengood, RA; Southwick, SM; and Siever, LJ. Hypothalamic-pituitary-adrenal functioning in posttraumatic stress disorder. In: Friedman, MJ; Charney, DS; and Deutch, AY, eds. Neurobiological and Clinical Consequences of Stress. Philadelphia, PA: Lippincott-Raven, 1995.
60. Yehuda, R, and McFarlane, AC. Conflict between current knowledge about posttraumatric stress disorder and its original conceptual basis. Am. J. Psychiatry 152:1705-1713, 1995.
61. Yehuda, R; Resnick, H; Kahana, B; and Giller, EL. Long lasting hormonal alterations to extreme stress in humans: Normative or mal-adaptive? Psychosom. Med. 55:287-297, 1993.
62. Yehuda, R; Levengood, RA; Schmeidler, J; Wilson, S; Guo, LS; and Gerber, D. Increased pituitary activation following metyrapone administration in post-traumatic stress disorder. Psychoneuroendocrinology 21:1-16, 1996.
63. Zaidi, LY, and Foy, DW. Childhood abuse experiences and combat related PTSD. J. Traum. Stress 7:33-42, 1994.